Author:
Gnanasekaran Krishna Kumar,Pouland Tim,Bunce Richard A.,Darrell Berlin K.,Abuskhuna Suaad,Bhandari Dipendra,Mashayekhi Maryam,Zhou Donghua H.,Benbrook Doris M.
Funder
Stephenson Cancer Research Center/Oklahoma Tobacco Settlement Endowment Trust
NSF
Oklahoma State Regents for Higher Education
W. M. Keck Foundation, and Conoco, Inc
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference40 articles.
1. SHetA2 interference with mortalin binding to p66shc and p53 identified using drug-conjugate magnetic microspheres;Benbrook;Invest New Drugs,2014
2. SHetA2–A minireview of a promising anti-cancer agent;Nammalwar;J. SciMed Chem.,2013
3. Liu, S., Zhou, G., Lo, S.N.H., Louie, M., Rajagopalan V. SHetA2, a new cancer-preventive drug candidate. Chapter 3 in Anti-cancer drugs, nature synthesis and cell, 2016; In Tech D.O.O., Janeza Trdine 9, 51000 Rijeka, Croatia, ISBN: 978-953-51-2814-4.
4. 1,2,3,4-Tetrahydroquinolines, 2,3-dihydro-4(1H)-quinolin-ones and 4(1H)-quinolinones using domino reactions;Nammalwar;Molecules,2014
5. Biologically active heteroarotinoids exhibit anticancer activity and decreased toxicity;Benbrook;J Med Chem,1997
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献